We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
+0.39%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$69.6B
AUM Growth
+$2.44B
(+3.6%)
Cap. Flow
+$2.78B
Cap. Flow
% of AUM
4%
Top 10 Holdings %
Top 10 Hldgs %
16.69%
Holding
760
New
59
Increased
405
Reduced
179
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
American International
AIG
|
+$473M |
| 2 |
HP
HPQ
|
+$383M |
| 3 |
Occidental Petroleum
OXY
|
+$349M |
| 4 |
Target
TGT
|
+$343M |
| 5 |
Cigna
CI
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
OCR
OMNICARE INC
OCR
|
+$333M |
| 2 |
LO
LORILLARD INC COM STK
LO
|
+$244M |
| 3 |
Marathon Petroleum
MPC
|
+$236M |
| 4 |
Home Depot
HD
|
+$201M |
| 5 |
AbbVie
ABBV
|
+$178M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 26.04% |
| 2 | Technology | 15.47% |
| 3 | Healthcare | 15.3% |
| 4 | Industrials | 11.92% |
| 5 | Consumer Discretionary | 7.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BMCH
301
DELISTED
BMC Stock Holdings, Inc
BMCH
| $20.4M | 0.03% |
1,042,798
+147,345
| +16% | +$2.76M |
|
|
TRIB
302
Trinity Biotech
TRIB
$5.7M
| $20.4M | 0.03% |
7,523
+1,987
| +36% | +$5.16M |
|
|
ACRE
303
Ares Commercial Real Estate
ACRE
$252M
| $20.1M | 0.03% |
1,764,812
+260,478
| +17% | +$3M |
|
304
Brady Corp
BRC
$4.45B
| $20.1M | 0.03% |
811,380
+124,773
| +18% | +$3.27M |
|
305
FTI Consulting
FCN
$4.82B
| $20M | 0.03% |
484,698
-221,472
| -31% | -$8.83M |
|
|
AREX
306
DELISTED
Approach Resources Inc.
AREX
| $19.9M | 0.03% |
2,907,590
+58,110
| +2% | +$438K |
|
307
First Citizens BancShares
FCNCA
$24.6B
| $19.8M | 0.03% |
75,346
+9,299
| +14% | +$2.31M |
|
|
LBY
308
DELISTED
Libbey, Inc.
LBY
| $19.7M | 0.03% |
477,051
-29,099
| -6% | -$1.18M |
|
309
Employers Holdings
EIG
$908M
| $19.6M | 0.03% |
862,220
+94,831
| +12% | +$2.32M |
|
|
PRXL
310
DELISTED
Parexel International Corp
PRXL
| $19.6M | 0.03% |
304,485
+32,277
| +12% | +$2.17M |
|
|
TGI
311
DELISTED
Triumph Group
TGI
| $19.6M | 0.03% |
296,288
+21,879
| +8% | +$1.42M |
|
312
Nelnet
NNI
$4.79B
| $19.3M | 0.03% |
446,487
-17,749
| -4% | -$780K |
|
313
Intel
INTC
$466B
| $19.1M | 0.03% |
+628,355
| New | +$20.3M |
|
314
Central Pacific Financial
CPF
$997M
| $18.9M | 0.03% |
794,431
-223,060
| -22% | -$5.2M |
|
|
ACH
315
Accendra Health
ACH
$240M
| $18.8M | 0.03% |
553,659
+58,992
| +12% | +$1.99M |
|
316
FerroAtlántica
GSM
$628M
| $18.7M | 0.03% |
1,055,737
+71,355
| +7% | +$1.42M |
|
317
Mativ Holdings
MATV
$448M
| $18.6M | 0.03% |
467,161
+168,904
| +57% | +$7.16M |
|
318
Upbound Group
UPBD
$1.19B
| $18.5M | 0.03% |
653,625
+82,128
| +14% | +$2.46M |
|
|
HOLI
319
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $18.5M | 0.03% |
770,776
+520,776
| +208% | +$12.5M |
|
|
HI
320
DELISTED
Hillenbrand
HI
| $18.5M | 0.03% |
602,641
+81,020
| +16% | +$2.5M |
|
|
UCB
321
United Community Banks
UCB
$4.22B
| $18.4M | 0.03% |
883,360
+151,463
| +21% | +$2.91M |
|
|
FGL
322
DELISTED
Fidelity & Guaranty Life
FGL
| $17.8M | 0.03% |
753,000
-12,690
| -2% | -$286K |
|
323
Kemper
KMPR
$1.7B
| $17.7M | 0.03% |
459,300
+21,520
| +5% | +$813K |
|
|
KNL
324
DELISTED
Knoll, Inc.
KNL
| $17.6M | 0.03% |
704,614
+88,537
| +14% | +$2.09M |
|
|
KW
325
DELISTED
Kennedy-Wilson Holdings
KW
| $17.6M | 0.03% |
715,590
+27,170
| +4% | +$695K |
|
Similar funds
Boston Partners's Q2 2015 Portfolio in Review
As of Q2 2015, Boston Partners held 760 positions worth $69.6B, up 3.6% from $67.2B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Boston Partners deployed $2.78B of net new capital in Q2 2015, opening 59 new positions and adding to 405 existing holdings. Its largest new stake was Target: 4,243,475 shares worth $346M.
By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 25% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was OMNICARE INC, an estimated $333M trimmed.
- Boston Partners's largest Q2 2015 buy was Target: 4,243,475 shares worth $346M.
- Boston Partners added most to American International in Q2 2015, an estimated $473M increase.
- Boston Partners's biggest Q2 2015 reduction was OMNICARE INC, cutting an estimated $333M.
- Boston Partners fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $244M.
- Boston Partners's ten largest holdings make up 17% of its $69.6B portfolio in Q2 2015.
- Boston Partners opened 59 new positions and closed 58 in Q2 2015.
- Boston Partners's portfolio value rose 3.6% quarter-over-quarter to $69.6B.
Based on Boston Partners's 13F filing for Q2 2015, filed 10 Aug 2015.